Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 9 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 267 Neoplasms 177 Colorectal Neoplasms 133 Stomach Neoplasms 107 Uterine Cervical Neoplasms 96 Carcinoma, Non-Small-Cell Lung 89 Prostatic Neoplasms 83 Lung Neoplasms 78 Carcinoma, Hepatocellular 73 Rectal Neoplasms 64 Ovarian Neoplasms 54 Esophageal Neoplasms 53 Pancreatic Neoplasms 52 Colonic Neoplasms 52 Recurrence 43 Multiple Myeloma 39 Neoplasm Metastasis 38 Head and Neck Neoplasms 37 Endometrial Neoplasms 36 Precursor Cell Lymphoblastic Leukemia-Lymphoma 35 Motor Activity 34 Melanoma 33 Polycystic Ovary Syndrome 32 Lymphoma 32 Urinary Bladder Neoplasms 31 Leukemia, Myeloid, Acute 30 Thyroid Neoplasms 29 Small Cell Lung Carcinoma 28 Nasopharyngeal Carcinoma 25 Lymphoma, Non-Hodgkin 25

Interventions

Heparin 1 Enoxaparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Malignant Female Reproductive System Neoplasm × Clear all

NCT01356329 2016-05-13

Lovenox

National Guard Health Affairs

Phase 3 Suspended

Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡